We observed that the p38 and p42/44 inhibitors repressed the IL1B-mediated induction of OPG mRNA (Fig. 3a) and secreted OPG protein (Fig. 3b) in all three breast cancer cell lines tested. Here, TNFRSF11B is linked to breast cancer.